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Circulating microRNAs have proven to be reliable biomarkers, due to their high stability,
both in vivo in the circulation, and ex vivo during sample preparation and storage.
Small nucleolar RNAs (snoRNAs) are a different type of small non-coding RNAs that
can also be reliably measured in plasma, but have only been studied sporadically. In
this study, we aimed to identify RNA-biomarkers that can distinguish between different
exercise regimes and that entail clues about muscle repair and recovery after prolonged
exhaustive endurance exercise. We compared plasma microRNA profiles between
two cohorts of elite cyclists, subjected to two different types of exercise regimes, as
well as a cohort of patients with peripheral artery disease (PAD) that were scheduled
to undergo lower limb amputation, due to critical limb ischemia. In elite athletes,
muscle tissue recovers quickly even after exhaustive exercise, whereas in PAD patients,
recovery is completely impaired. Furthermore, we measured levels of a specific group of
snoRNAs in the plasma of both elite cyclists and PAD patients. Using a multiplex qPCR
screening, we detected a total of 179 microRNAs overall, of which, on average, 161
microRNAs were detected per sample. However, only 30 microRNAs were consistently
expressed in all samples. Of these, two microRNAs, miR-29a-3p and miR193a-5p,
that responded differently two different types of exercise, namely exhaustive exercise
and non-exhaustive endurance exercise. Using individual rt/qPCR, we also identified
a snoRNA, SNORD114.1, which was significantly upregulated in plasma in response
to endurance exercise. Furthermore, two microRNAs, miR-29a-3p and miR-495-3p,
were significantly differentially expressed in athletes compared to PAD patients, but only
following exercise. We suggest that these two microRNAs could function as markers
of impaired muscle repair and recovery. In conclusion, microRNAs miR-29a-3p and
miR-193a-5p may help us distinguish between repeated exhaustive and non-exhaustive
endurance exercise. MicroRNA miR-29a-3p, as well as miR-495-3p, may further mark
impaired muscle recovery in patients with severe critical limb ischemia. Furthermore,
we showed for the first time that a circulating snoRNA, SNORD114.1, is regulated in
response to exercise and may be used as biomarker.
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INTRODUCTION
Regular exercise at moderate intensity has clear benefits for
general health, overall fitness, quality of life and importantly,
cardiovascular physiology. Exercise at elite level however, is
far more demanding of the body and muscles. During high
intensity endurance exercise, muscle glycogen is the major
energy substrate and metabolic stress develops. Moreover,
exercise triggers an increase in cytokine production, attraction of
leukocytes, upregulation of pro-angiogenic stimuli and an overall
pro-inflammatory state (Ulven et al., 2015; Langleite et al., 2016).
In healthy individuals however, during restitution and repletion
of glycogen levels, the inflammation is dampened and over time,
muscle function improves.
In patients with peripheral artery disease (PAD), poor
circulation leads to a chronic ischemia and low levels of nutrients
in the affected limb(s). PAD is caused by chronic accumulation
of atherosclerotic lesions in the arteries of the limbs, generally
of the leg (Abul-Khoudoud, 2006). Besides lifestyle changes,
such as cessation of smoking and increased moderate exercise,
and management of risk factors, such as cholesterol lowering,
there are no therapeutics available that effectively treat PAD.
Patients with severe PAD are at risk of developing critical
limb ischemia, defined by cramp-like pain even at rest. Unless
blood flow is recovered via physiological neovascularization (i.e.,
arteriogenesis and angiogenesis), or via surgical revascularization
(i.e., stenting or bypass surgery), the pro-inflammatory state
becomes permanent and instead of recovery, muscle tissue will
start to degrade and ultimately become necrotic. In such severe
cases, the only remaining treatment option to prevent sepsis and
death is amputation of the affected limb (Germani et al., 2009).
Both in exercise physiology and in PAD pathology, researchers
have been trying to identify reliable biomarkers to follow muscle
repair and recovery. In exercise physiology, such biomarkers
could be used to improve training and recovery schedules
to optimize competitive performance. Whereas in PAD, such
biomarkers may assist vascular surgeons and PAD patients in
their joint decision-making before surgical intervention, it being
revascularization or even amputation. Although the respective
perspectives are very different, potentially, both fields of research
could stand to benefit from each other.
In recent years, circulating microRNAs have proven to be
highly reliable biomarkers (Mitchell et al., 2008; Hakimzadeh
et al., 2015). MicroRNAs are small, non-coding RNA molecules
that inhibit the translation of messenger RNAs by binding to
their 3′ untranslated regions (Bartel, 2004). Although microRNAs
exert their function intracellularly, microRNAs can also be
released into the circulation, either passively upon tissue damage,
or actively bound to lipid particles such as HDL, or in
microvesicles or exosomes. Microvesicles are also released upon
exercise (Wilhelm et al., 2016; Whitham et al., 2018). While
extracellular RNA is usually rapidly digested by endogenous
RNases, the short length of microRNAs (around 20 nucleotides)
protects them from most RNase degradation and gives them
relative extracellular stability (Mitchell et al., 2008). Furthermore,
microRNA are often highly tissue- or pathway-specificity. Within
muscle physiology, muscle-specific microRNAs (myomiRs) such
as miR-1 miR-133a, miR-133b, and miR-206 have indeed been
detected in the circulation after exercise (Horak et al., 2016).
Other studies have shown that non-myomiRs, including the
hepatic miR-122, are also increased in the circulation during
exercise trials (Cui et al., 2015).
Research into other types of non-coding RNAs, including
small nucleolar RNA (snoRNA) has increased as well over the
past few years, but little is known about their role in exercise and
muscle physiology. Similar to microRNAs, snoRNAs are small,
highly conserved RNAs. Their canonical function is to stabilize
other RNA species, either through 2′O-ribose-methylation (Kiss,
2001), or through pseudouridylation. SnoRNAs have been shown
to be reliably measurable in plasma, making them promising
candidates for biomarkers, much like microRNAs (Liao et al.,
2010).
Besides increased extracellular stability in vivo, small non-
coding RNAs have also proven to be highly stable ex vivo, resisting
degradation due to poor sample handling, repetitive freeze-
thawing and long-term storage. This remarkable stability may
give small non-coding RNAs a further advantage as biomarkers
(Peiro-Chova et al., 2013).
In this study, we have performed a screening for circulating
microRNAs regulated after exhaustive endurance exercise in
a cohort of elite cyclists. Regulated microRNAs were then
confirmed and further investigated in a second cohort of elite
cyclists performing a 60 min time trial at highest possible
intensity. Furthermore, plasma microRNAs were compared
between an athlete cohort and a cohort of PAD patients
hospitalized for critical limb ischemia, scheduled for lower limb
amputation. Finally, we measured levels of a specific group of
snoRNAs in the plasma of both elite cyclists and PAD patients.
By comparing the effects of muscle exhaustion on circulating
non-coding RNAs between these two extreme ends of the
spectrum, from highly trained elite-cyclists to patients in the end-
stage of PAD, we aimed identify strong and reliable biomarkers
for muscle repair and recovery.
MATERIALS AND METHODS
A schematic overview of our study set-up is presented in Figure 1.
Exhaustive Endurance Exercise (EEE)
Cohort
Subjects
Eight male elite endurance cyclists (mean ± SD; age:
22.9 ± 1.2 years; height: 182 ± 2 cm; body mass: 79.5 ± 3 kg)
were recruited for our cohort. All subjects had competitive
experience at national or international level and trained, 16± 1 h
weekly, of which 12± 2 h was cycling.
This study was carried out in accordance with the
recommendations of Guidelines for Human Exercise Trials,
Norwegian School of Sport Sciences’ Ethics Committee. The
protocol was reviewed by Regional Ethic Committee of Norway
(2011/1298) with the decision that the research project was
outside the Act on Medical Health Research, confirmed in letter
of exemption (2011/1298; IRB Reference No. IRB00006245). The
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FIGURE 1 | Schematic representation of the study cohorts and set-up. Please note that details on warming-up, etc. are not provided (see section “Materials and
Methods”).
study was conducted according to the Declaration of Helsinki
and participants gave their informed written consent after oral
and written information about the study.
Study Set-Up
Before trial start, subjects completed a familiarization session
with a self-paced warm up and a possibility for subjects to adjust
the ergometer (Lode Excalibur Sport, Groningen, Netherlands)
geometry to individual preferences, as previously described
(Rustad et al., 2016). Linear regression was used to identify the
workload corresponding to 73% of VO2max (W73%).
On the first trial day an exhaustive exercise session was
performed. The session started with a warm up as described
previously (Rustad et al., 2016). After 5 min of recovery, subjects
performed a 10 s all-out effort sprint followed by another 5 min
of recovery. The exhaustive exercise session started with 30 min
at W73%, followed by another 5 min of recovery. Subsequent
intervals of 20 min at W73% with 5 min of rest between
intervals were performed until subjects were unable to maintain
predetermined cadence± 5RPM. After exhaustion, athletes were
given 5 min of recovery, followed by repeated intervals of 60 s
at 90% VO2max-sprints with 60 s of rest between sprints until
voluntary exhaustion. Blood samples were drawn at baseline and
at 120 min after the exercise session.
On the second day, roughly 18 h after finishing the first
exhaustive exercise session, subjects completed the same warm
up as on the previous day. After warm up, 5 min of recovery
was followed by a 10 s sprint, followed by 30 min cycling
at W73%. After 5 min rest, a time test was performed with a
predetermined amount of work [Work (kJ) = Power at VO2max
(W) ∗ 1800 s]. Initial workload was set to W73%, but the athletes
were free to adjust workload to personal preference. Five minutes
after the time-trial participants performed a 10 s all-out effort
sprint. Blood was drawn before warm up and immediately after
completion of the exercise session.
Sample Collection
Blood was drawn from the antecubital vein using a Teflon
catheter (18GA, BD Venflon Pro, Franklin Lakes, NJ,
United States) into EDTA-coated tubes and centrifuged
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(2500 g, 10 min) at 4◦C. Plasma was transferred to 1.5 ml tubes
and stored at−80◦C until analysis.
Peripheral Artery Disease (PAD) Cohort –
Ampubase
Subjects
Sixteen patients (87.5% male; age: 69± 13 years) from the Leiden
University Medical Center biobank Ampubase were included in
our study. All patients were scheduled for lower limb amputation,
either below or above the knee joint as a consequence of
critical limb ischemia. Inclusion criteria for the biobank were a
minimum age of 18 years and lower limb amputation, excluding
ankle, foot, or toe amputations. Exclusion criteria were confirmed
or suspected malignancy and inability to give informed consent.
The study was approved by the Medical Ethics Committee of
the Leiden University Medical Center (Protocol No. P12.265) and
written informed consent was obtained from all participants.
Sample Collection
Blood samples were collected pre-operatively. Sample collection
followed standard hospital procedures. Blood was collected in
citrate coated tubes and immediately put on ice. Samples were
processed within 30 min of collection and were centrifuged for
10 min at 2800 g at 4◦C. Plasma was then aliquoted and the
plasma closest to the buffy coat was discarded. Aliquots were
stored at−80◦C until analysis.
Time Trial (TT60) Cohort
Study Population
Thirteen highly trained, male endurance cyclists (mean ± SD;
age: 27.7 ± 1.2 years; height: 184 ± 1 cm; body mass:
77.2 ± 1.1 kg) were recruited for this study. All subjects had
competitive experience at national or international level and
trained for 11.5 ± 1.2 h weekly, of which 8.8± 1.4 h was cycling.
Due to sample depletion, only 10 athletes with complete sets of
samples were included in our analyses.
All subjects were informed of any potential risks before
acquiring their written informed consent. The project was
approved by Regional Ethics Committee (2013/1528) of Norway,
and performed according to the Declaration of Helsinki.
Study Set-Up
The initial pre-trial testing, analysis and equipment used in the
second cohort was identical to the EEE cohort, described above.
On the day of the trial, subjects started with a standardized
warm up of 5–2 min of 50, 55, 60, and 75% of the pre-trial
VO2max, respectively. The exercise session was started with a 10 s
all-out sprint immediately followed by 4 min of active (100W)
or passive restitution. After initial restitution, participants cycled
30 min at W73%, followed by a 60 min time trial separated by
5 min of restitution. The session ended with another 10 se all-out
sprint.
Blood samples were drawn before exercise, immediately after
exercise completion as well as after 2 and 5 h of restitution.
Sample Collection
Blood was drawn from the antecubital vein using a Teflon
catheter (18GA, BD Venflon Pro, Franklin Lakes, NJ,
United States) into EDTA-coated tubes. Samples were stored
on ice until centrifugation (10 min, 2500 g) at 4◦C, after which
plasma was aliquoted and stored at −80◦C until subsequent
analysis.
RNA Isolation and Quantification
Plasma samples from five male EEE Cohort participants and
five male Ampubase Cohort participants, were sent to Exiqon
Services, Exiqon A/S (Vedbæk, Denmark) for RNA isolation,
reverse transcription and Multiplex Circulating MicroRNA qPCR
Panel for microRNA expression analysis, using their in-house
products and protocols. Samples were selected on relative
homogeneity in age and other physical parameters.
Total RNA from 100 µL of plasma was extracted using the
miRCURY RNA Isolation Kit – Biofluids (Exiqon, Vedbæk,
Denmark), including rDNase treatment to prevent DNA
contamination. RNA was stored until further analysis at−80◦C.
RNA was reverse transcribed using the miRCURY LNA
Universal microRNA PCR, Polyadenylation and cDNA Synthesis
Kit. Each microRNA was assayed by qPCR using microRNA
Ready-to-Use PCR, Serum/Plasma Focus panel using ExiLENT
SYBR Green Master Mix. Negative controls were included
as master mix without cDNA template. Amplification was
performed using the LightCycler 480 Real-Time PCR System
(Roche Molecular Diagnostics, Pleasanton, CA, United States).
Amplification curves were analyzed using the Roche LC
software, both for determination of Cq and for melt curve
analysis.
Amplification efficiency was calculated using Exiqon’s in-
house algorithms similar to the LinReg software. Melting curves
and temperatures of all assays were within specifications of the
assays. All measurements with five Cqs less than the negative
control and with a Cq < 37 were included in the analysis.
Data that did not meet these criteria were omitted from further
analyses. All data were normalized to the average of all assays in
all samples (average Cq – assay Cq).
For snoRNA and confirmatory microRNA analyses, total RNA
was isolated from all available plasma samples using TRIzol-
LS Reagent, according to the Manufacturer’s protocol (Thermo
Fisher, Waltham, MA, United States).
For snoRNAs analyses, RNA was reverse transcribed using
‘High-capacity RNA to cDNA kit’ (Thermo Fisher, Waltham,
MA, United States) and quantified by RT-qPCR using SybrGreen
reagent (Qiagen, Venlo, Netherlands) on the VIIa7 (Thermo
Fisher, Waltham, MA, United States). All qPCR reactions were
performed in technical triplicates. The Coefficient of Variance
(Cv =6/µ) was calculated and triplicates resulting in a Cv > 0.02
were excluded. SnoRNA expression was normalized to U6.
For confirmatory microRNA quantification, RNA was
reversed transcribed and subsequently quantified using
microRNA specific Taqman qPCR kits (Thermo Fisher,
Waltham, MA, United States). All qPCR reactions were
performed in technical triplicates. The Cv was calculated and
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triplicates resulting in a Cv > 0.02 were excluded. MicroRNA
expression was normalized to miR-191.
Statistical Analysis
All statistical analyses, unless otherwise specified, were performed
using GraphPad Prism 7 (GraphPad Software, Inc., San Diego,
CA, United States). p-Values of < 0.05 were regarded as
significant, p-values < 0.1 were regarded as a trend. Normalized
relative expression values are presented as mean ± SEM. Due
to large inter-sample variation, Grub’s test was used to identify
significant (α< 0.05) outliers in ncRNA measurements.
One-way analyses of variance (ANOVA) was used to
determine differences in expression levels over time within
a cohort. To identify significant effects within ANOVAs, the
Tukey’s Honest Significant Difference-test was used as a post hoc
test for multiple comparisons.
When comparing mean expression between different cohorts
two-tailed Student’s t-test were used, paired or unpaired,
depending on within or between group comparisons. Values are
presented as the fold change between groups.
RESULTS
Exhaustive Endurance Exercise and
Peripheral Arterial Disease
Samples drawn from five participants of the EEE and five
participants of the PAD cohorts were sent to Exiqon in
Denmark for multiplex rt/qPCR expression profiling. The
multiplex panel measures a total of 179 microRNA, of which,
on average, 161 microRNAs were detected per sample. 30
microRNAs were consistently detected in all samples. Although
all samples passed quality control, the microRNA content, both
in number of detected microRNAs and expression levels of
the detected microRNAs, was lowest in PAD cohort samples
(Figure 2).
When allowing unsupervised clustering on expression data
of the 30 microRNAs expressed in all samples, it is obvious
from the heatmap (Figure 3) that all PAD samples cluster
together and are clearly different from the athletes’ samples.
When looking at the athletes’ samples, overall clusters are formed,
mostly per individual. Inter-individual differences in microRNA
profiles are bigger than exercise-induced differences. However,
several individual microRNAs were significantly regulated either
in response to exhaustive exercise, or in response to recovery
(Tables 1A–C).
Table 1A shows two microRNAs that are upregulated directly
in response to exhaustive exercise, miR-193a-5p (3.3-fold) and
miR-29a-3p (1.3-fold). MiR-29a-3p is the only microRNA that
is also regulated after the second exercise session (1.5-fold)
(Table 1C), and thus potentially the most reliable biomarker for
muscle exhaustion. As shown in Table 2C, multiple microRNAs
are regulated in response to a second exercise session. Two
microRNAs, miR-99b-5p and miR-151a-3p are downregulated
(or depleted) the morning after the first exercise session (−1.6-
and −1.2-fold, respectively) (Table 1B), indicating that they
may be involved in the recovery process. Unfortunately, these
microRNAs did not differ, at any time point, from the PAD
samples (Tables 2A–D), our pathological model for impaired
muscle recovery.
As expected, the number of differentially expressed
microRNAs between athletes and PAD patients at any given
time point is much larger than between time points within the
group of athletes (Tables 2A–D). However, there are several
changes in circulating microRNA expression profiles. There are
several microRNAs that lose their difference to PAD samples
directly after the second exercise session. MiR-193a-5p even
loses its significant difference from PAD samples already after
FIGURE 2 | Graphical illustration of the microRNA content in the EEE and PAD cohorts. The blue bars represent the number of microRNAs detected in each sample
and the red line shows the average Cq-value for the commonly expressed microRNAs. On average, 161 microRNA were detected per sample. BC, before cycling;
AF, after 1st cycling; MA, morning after; A2C, after 2nd cycling; PAD, peripheral artery disease.
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FIGURE 3 | Heat map and unsupervised hierarchical clustering. The clustering was performed on all samples, and on the top 30 microRNAs with highest standard
deviation. The normalized expression values (dCq) were used for the analysis. BC, before cycling; AF, after 1st cycling; MA, morning after; A2C, after 2nd cycling;
PAD, peripheral artery disease.
the first exercise session. One specific microRNA, miR-495-3p is
significantly upregulated in response to both exercise sessions,
compared to the PAD samples (3.7- and 4.5-fold, respectively).
The microarray data are available via the Gene Expression
Omnibus (GEO1) via Accession No. GSE117654.
Time Trial Exercise and Peripheral
Arterial Disease
We selected nine microRNAs to be measured in a second,
but different exercise cohort, where elite cyclists were subjected
to a strenuous, but non-exhaustive, time trial. MiR-29a-3p,
miR-193a-5p, miR-495-3p, miR-106b-5p, and miR-155-3p were
selected based on our findings in the EEE cohort. MiR-1-3p, miR-
133a-3p, miR-133b-3p, and miR-122-5p were selected based on
1https://www.ncbi.nlm.nih.gov/geo/
literature describing their regulation in plasma in response to
exercise (Cui et al., 2015; Horak et al., 2016).
MiR-29a-3p and miR-193a-5p were both upregulated at 2 h
after exhaustive exercise (Figure 4; ANOVA p = 0.0019 and
p = 0.0924, respectively). Two hours after the time trial however,
both microRNAs were significantly downregulated. Both miR-
106b-5p and miR-155-5p were also downregulated after the time
trial, but both microRNAs normalized rapidly (Figure 4; ANOVA
p = 0.0293 and p = 0.0058, respectively).
Of the ‘myomiRs,’ only miR-133b-3p was regulated
significantly in response to the time trial, although a similar trend
was observed for miR-1-3p (ANOVA p = 0.0179 and p = 0.0949,
respectively). Both microRNAs appeared upregulated directly
after the time trial and decreased in expression during recovery.
When compared to the PAD cohort, we again observed
that microRNA expression profiles differ strongly between
elite athletes and patients with critical limb ischemia. Most
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TABLE 1 | Regulation of microRNAs in response to exercise.
MicroRNA Fold change p-Value
(A) Two hours after compared to before cycling
hsa-miR-193a-5p 3.3 0.0066
hsa-miR-29a-3p 1.3 0.0081
(B) The morning after compared to before cycling
hsa-miR-99b-5p −1.6 0.0074
hsa-miR-151a-3p −1.2 0.048
(C) After 2nd cycling compared to before cycling
hsa-miR-142-3p 1.3 0.0014
hsa-miR-29a-3p 1.5 0.0026
hsa-miR-106b-5p −1.3 0.0058
hsa-miR-141-3p 1.6 0.0082
hsa-miR-30d-5p −1.2 0.011
hsa-miR-150-5p 1.9 0.028
hsa-miR-424-5p 1.6 0.030
hsa-miR-23a-3p −1.2 0.031
hsa-let-7g-5p 1.3 0.033
hsa-miR-423-3p 1.5 0.034
of the microRNAs that we measured, including miR-193a-5p,
miR155-5p, miR133a-3p, miR-133b-3p, and miR-122-5p were
lower in athletes than in PAD patients at all time points,
both before and after exercise. Consistent with the EEE cohort
however, miR29a-3p and miR-495-3p only became different from
the PAD cohort after exercise. MiR-29a-3p was significantly lower
in the TT60 cohort than in the PAD cohort, directly and at
2 h after the time trial. MiR-495-3p was borderline-significantly
lower (p = 0.053) in the TT60 cohort than in the PAD cohort in
the later stages of recovery, at 5 h after the time trial.
SnoRNA Expression in the TT60 and PAD
Cohorts
SnoRNAs are also small non-coding RNA molecules that can
be reliably measured in human plasma (Liao et al., 2010). As
‘snoRnome-wide’ screening methods are not yet readily available,
we selected a specific subset of snoRNAs and measured these by
rt/qPCR, in order to determine whether or not snoRNAs may
be suitable as biomarkers for either exercise or muscle recovery.
We selected seven snoRNAs that are expressed from a single gene
locus, 14q32, which also encodes 54 microRNA genes, including
miR-495-3p, that we know are involved in angiogenesis and
vascular remodeling (Welten et al., 2014, 2017).
All seven snoRNAs could indeed be detected in human
plasma. However, especially in the exercise cohort, some
snoRNAs were expressed below detection levels in some
individual athletes. One snoRNA, SNORD114.1 was significantly
upregulated over time after the time trial. SNORD114.1 levels
increased gradually throughout the recovery period (p = 0.022).
When comparing athletes to PAD patients, the snoRNAs were
either different between both cohorts at all TT6o time points
(SNORD112, SNORD113.2, SNORD113.6, and SNORD 114.1)
or at none or the TT60 time points (SNORD113.7, SNORD113.8,
and SNORD113.9). Expression levels of the snoRNAs are
presented in Figure 5.
TABLE 2 | Differential expression of microRNAs between elite cyclists and patients
with PAD.
MicroRNA Fold change p-Value
(A) Before cycling compared to PAD
hsa-miR-483-5p −21 0.000032
hsa-miR-130a-3p 4.4 0.00031
hsa-miR-2110 −2.5 0.00040
hsa-miR-155-5p −9.4 0.00060
hsa-miR-19a-3p 5.8 0.00075
hsa-miR-21-5p 3.6 0.0015
hsa-miR-19b-3p 4.6 0.0019
hsa-miR-144-5p −9.5 0.0020
hsa-miR-148b-3p 2.9 0.0025
hsa-miR-101-3p 4.8 0.0030
hsa-miR-30c-5p −3.7 0.0035
hsa-miR-590-5p 5.1 0.0037
hsa-let-7a-5p −4.4 0.0044
hsa-miR-27b-3p 8.6 0.0047
hsa-miR-122-5p −6.1 0.0059
hsa-miR-193a-5p −12 0.0064
hsa-miR-335-5p 4.5 0.0082
hsa-miR-106b-5p 2.4 0.0090
hsa-miR-103a-3p −3.5 0.011
hsa-miR-107 −3.5 0.011
(B) Two hours after cycling compared to PAD
hsa-miR-2110 −2.7 0.000018
hsa-miR-130a-3p 4.5 0.00036
hsa-miR-19a-3p 5.4 0.00063
hsa-miR-144-5p −12 0.0011
hsa-miR-483-5p −22 0.0014
hsa-miR-148b-3p 2.9 0.0020
hsa-miR-21-5p 3.3 0.0021
hsa-miR-19b-3p 4.6 0.0022
hsa-miR-101-3p 5.0 0.0023
hsa-miR-122-5p −5.6 0.0023
hsa-miR-590-5p 5.0 0.0045
hsa-miR-30c-5p −3.2 0.0052
hsa-miR-27b-3p 8.2 0.0053
hsa-miR-155-5p −8.5 0.0055
hsa-let-7a-5p −3.4 0.0060
hsa-miR-335-5p 4.1 0.010
hsa-miR-103a-3p −3.4 0.011
hsa-miR-106b-5p 2.2 0.012
hsa-miR-107 −3.8 0.012
hsa-miR-495-3p 3.7 0.014
(C) The morning after compared to PAD
hsa-miR-122-5p −9.8 0.00044
hsa-miR-130a-3p 4.3 0.00065
hsa-miR-483-5p −23 0.00069
hsa-miR-19a-3p 5.8 0.00082
hsa-miR-155-5p −5.4 0.0011
hsa-miR-144-5p −11 0.0017
hsa-miR-21-5p 3.4 0.0019
hsa-miR-101-3p 5.3 0.0019
hsa-miR-30c-5p −3.9 0.0024
(Continued)
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TABLE 2 | Continued
MicroRNA Fold change p-Value
hsa-miR-19b-3p 4.7 0.0028
hsa-miR-145-5p −2.2 0.0032
hsa-miR-335-5p 6.3 0.0034
hsa-let-7a-5p −4.4 0.0039
hsa-miR-148b-3p 2.7 0.0039
hsa-miR-27b-3p 7.7 0.0051
hsa-miR-2110 −3.5 0.0059
hsa-miR-590-5p 5.1 0.0069
hsa-miR-885-5p −11 0.0071
hsa-miR-193a-5p −11 0.0079
hsa-miR-103a-3p −3.7 0.0095
(D) After 2nd cycling compared to PAD
hsa-miR-19a-3p 5.9 0.00023
hsa-miR-19b-3p 4.8 0.00068
hsa-miR-122-5p −8.8 0.0012
hsa-miR-130a-3p 5.6 0.0015
hsa-miR-144-5p −11 0.0015
hsa-miR-148b-3p 3.0 0.0022
hsa-miR-590-5p 5.8 0.0024
hsa-miR-21-5p 3.6 0.0027
hsa-miR-101-3p 5.2 0.0029
hsa-miR-30c-5p −3.5 0.0035
hsa-miR-27b-3p 8.2 0.0048
hsa-miR-483-5p −21 0.0055
hsa-miR-142-5p 6.9 0.0058
hsa-miR-107 −3.7 0.0064
hsa-miR-495-3p 4.5 0.0065
hsa-miR-335-5p 5.3 0.0066
hsa-miR-24-3p 3.3 0.0072
hsa-let-7a-5p −3.2 0.0075
hsa-miR-2110 −4.1 0.0092
hsa-miR-29b-3p 7.8 0.010
DISCUSSION
In this study, we explored the suitability of circulating small non-
coding RNAs, including microRNA and snoRNAs, as biomarkers
for exercise and muscle damage. We included two cohorts
of elite cyclists, subjected to two different types of exercise
regimes, as well as a cohort of patients with PAD that were
scheduled to undergo lower limb amputation, due to critical
limb ischemia. We identified several microRNAs, as well as one
snoRNA, that were regulated in plasma in response to strenuous
endurance exercise. Furthermore, we identified microRNAs that
may indicate impaired suboptimal muscle repair, as they were
only differentially regulated from PAD patients, during the
recovery phase in elite cyclists.
The first thing we noticed, when looking at the microRNA
profiling data after repeated exhaustive endurance exercise, was
the fact that differences in microRNA expression profiles are
much bigger between individuals than between the different
time points before, during, and after the 2-day exercise
regime. Although we did identify several microRNAs that
were significantly regulated in response to exercise, our group
of athletes was quite homogenous, consisting only of male
elite cyclists in their early twenties. MicroRNA expression is
highly variable between individuals and is often age-dependent.
Therefore, future replication studies in larger and more
heterogeneous cohorts are necessary to determine the most
reliable microRNA-biomarkers.
We did identify two microRNAs that were significantly
regulated in response to the first exhaustive exercise session,
miR-29a-3p and miR-193a-5p. MiR-29a-3p was the most
consistently regulated, as it was also upregulated on the
second day. MiR-29a-3p had also previously been shown to be
regulated in response to exercise (de Gonzalo-Calvo et al., 2015).
Both microRNAs were also regulated in the second exercise
cohort, in response to a 60 min time trial. However, after
non-exhaustive endurance exercise, both miR-29a-3p and miR-
193a-5p were downregulated in plasma. Although surprising, this
is a promising finding, because this could mean that levels of miR-
29a-3p and miR-193a-5p may help distinguish between different
exercise regimes and indicate the extent of muscle exhaustion in
athletes.
MiR29a-3p, like the other microRNAs of the miR-29-family,
plays a crucial role in the formation and maintenance of the
extracellular matrix and controls, amongst others, the production
of collagens. Less is known about the function of miR-193a, but
a recent study has shown that miR-193a interacts with High
mobility group box-1 (HMGB1) and has effects on angio- and
vasculogenesis (Khoo et al., 2017). HMGB1 is a well-described
nuclear protein with a central role in inflammation and apoptosis
(Yang et al., 2013). Whether or not miR-29a-3p and miR-
193-5p play a functional role in muscle physiology, or if they
are markers for changes in the musculature remains to be
determined.
A third microRNA, miR-106b-5p could potentially provide
information about the recovery after exercise. MiR-106b-5p is
downregulated in response to both exhaustive and endurance
exercise, but only immediately after exercise completion (after
the second exercise session) and to the 60 min time trial.
However, 2 h after the first exhaustive exercise session, and
also 2 h after completion of the 60 min time trial, miR-
106b-5p have already normalized to the same levels as before
exercise. MiR-106b-5p has previously been shown to be highly
expressed in skeletal muscle of diabetic patients (Gallagher et al.,
2010) and mouse studies show that miR-106b overexpression
result in skeletal muscle mitochondrial dysfunction and insulin
resistance (Zhang et al., 2013). Exercise has a well-known
effect on insulin resistance and sensitivity (Borghouts and
Keizer, 2000) and possibly, miR-106-5p plays a role in this
process.
When looking at the more classic myomiRs, only miR-133b-
3p and possibly miR-1-3p were regulated in response to exercise
after the 60 min time trial. But then again, reproducibility in
exercise biomarker studies appears relatively low throughout
literature. Many different microRNAs, as well as many different
cytokines have been reported to associate with various forms of
exercise over the years (Ultimo et al., 2018). One explanation
could be that different forms and intensities of exercise can have
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FIGURE 4 | MicroRNA expression in the TT60 and PAD cohorts. Individual sample values are represented by green (athletes) and red (PAD patients) symbols; means
with their corresponding SEMs are represented by black lines. ANOVAs were performed to determine circulating microRNA regulation over time and Tukey’s Honest
Significant Difference-tests were performed to determine differences between time points, within the TT60 cohort (N = 10; but not all samples gave detectable
microRNA levels at all time points). Differences between the PAD cohort (N = 16; but not all samples gave detectable microRNA levels at all time points) and different
time points of the TT60 cohort were analyzed using unpaired, two-tailed Student’s t-tests. #p < 0.1; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. (B,E,G–I) The TT60 and
PAD cohort levels are expressed on separate X-axes.
profoundly different physiological effects. Another explanation
could be that inter-individual differences are simply larger than
differences induced by the exercise regimes. Indeed, in our
unsupervised clustering of microRNA expression (Figure 3), we
observed that microRNAs are clustered by individual, rather than
by time point.
A major finding in the present study was that exercise
influences plasma snoRNA levels. snoRNAs have previously
been described to be stable in the circulation (Liao et al., 2010),
however, this is the first report of exercise-mediated regulation
of snoRNAs. SnoRNAs may provide more reliable biomarkers in
the future. Out of seven snoRNAs, SNORD114.1 is significantly
upregulated in response to exercise and increases further
during recovery. These seven snoRNAs were selected because
they are transcribed from the same gene locus as microRNA
miR-495-3p. However, if snoRnome-wide screening methods
were to become commercially available, snoRNAs may offer
much more information on muscle condition and recovery.
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FIGURE 5 | SnoRNA expression in the TT60 and PAD cohorts. Individual sample values are represented by green (athletes) and red (PAD patients) symbols; means
with their corresponding SEMs are represented by black lines. ANOVAs were performed to determine circulating snoRNA regulation over time and Tukey’s Honest
Significant Difference-tests were performed to determine differences between time points, within the TT60 cohort (N = 10; but not all samples gave detectable
snoRNA levels at all time points). Differences between the PAD cohort (N = 16; but not all samples gave detectable snoRNA levels at all time points) and different
time points of the TT60 cohort were analyzed using unpaired, two-tailed Student’s t-tests. #p < 0.1; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. (B–D,G) The TT60 and
PAD cohort levels are expressed on separate X-axes.
However, further exploratory studies are certainly necessary to
establish circulating snoRNAs as biomarkers for any form of
exercise.
Finally, we identified two microRNAs that may function
as markers of impaired muscle repair and recovery. Both
miR-29a-3p and miR-495-3p are significantly different in athletes
compared to PAD patients, but only following exercise. The fact
that these microRNAs differ significantly from PAD patients
specifically during the recovery stage indicates that plasma
levels of these microRNAs may be a marker for muscle repair.
Especially miR-495-3p is a promising candidate to mark impaired
muscle repair and end-stage PAD, as we have previously shown
that miR-495-3p is highly functional in a mouse model for
severe PAD (Welten et al., 2014). Inhibition of this microRNA
increases endogenous ischemia-induced neovascularization and
significantly increased angiogenesis and muscle perfusion.
MiR-495-3p is significantly upregulated in response to both
exercise sessions, compared to the PAD samples, which indicates
that miR-495-3p could be associated with repair processes that
are lacking in patients with severe PAD.
Our study design has several limitations. First, we did not
include non-exercise control groups in our exercise cohorts. Of
course, we measured levels of microRNAs and snoRNAs in all
participants before starting the different exercise regimes, but
as samples were taken at different time point over 2 days, we
could not correct for potential confounding factors like circadian
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rhythm. Similarly, due to our study design where only PAD
patients scheduled for limb amputation surgery were included in
the study, we did not include samples from PAD patients at other
time points. Finally, due to sample depletion, we were unable to
confirm the findings from the microarray analyses by qPCR in all
the samples of the EEE cohort.
CONCLUSION
In this study, we have investigated the regulation of circulating
small non-coding RNAs in response to exercise. MicroRNAs
miR-29a-3p, miR-193a-5p, and miR-106b-5p have shown to be
significantly regulated in the circulation in response to endurance
exercise. MiR-29a-3p and miR-193a-5p may even be able to
distinguish between repeated exhaustive and non-exhaustive
exercise. MicroRNAs miR-29a-3p and miR-495-3p may mark
impaired muscle recovery in patients with severe critical limb
ischemia. Furthermore, we showed for the first time that a
circulating snoRNA, SNORD114.1, is regulated in response to
endurance exercise.
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